Net sales increased 5.2% YoY and 3.4% against the plan due to increase of sales in dispensing pharmacy business, despite the impact of the COVID-19. Ordinary profit increased 35.6% YoY and 9.4% against the plan due to increase of sales.
Net sales increased 6.9% YoY and 5.0% against the plan due to the recovery in prescription volume at existing stores and the contribution of stores opened in previous year. Segment profit increased 25.3% YoY and 12.8% against the plan due to increase of sales.
Net sales up 4.6% YoY and declined 7.7% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of temporarily shorted opening hours and refrainment from going out under the spread of COVID-19. Segment loss was ¥1,125 million, ¥195 million below the plan.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
AIN Holdings Inc. published this content on 10 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 December 2021 01:51:03 UTC.
AIN Holdings Inc is a Japan-based company engaged in the pharmacy business and retail business. The Company operates through three business segments. The Pharmacy segment consists of dispensing pharmacy, the sale of generic drugs, recruitment business focusing on doctors and pharmacists, and consulting services related to the management and opening of dispensing pharmacies. The Retail segment consists of the management of cosmetics and drug stores. The Others segment is engaged in the sale of cosmetics, food and beverages, and the rental of buildings.